text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nDong-A Brasil Farmaceutica Ltda\n비상장\n2013.04.01\n경영참여\n2,194\n3,156,754\n\xa099.10\n305\n-3,156,754\n-305\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\xa0\n-\n\xa0 \xa0 \xa0 \xa0 \xa0-\n-\n-\nDong-A America Corporation\n비상장\n2014.11.28\n경영참여\n256\n300\n\xa0100.00\n256\n-\n-\n-\n300\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 100.00\n256\n854\n0\n동아참메드\n비상장\n2021.09.02\n경영참여\n33,034\n70,000\n\xa0100.00\n7,673\n249,406\n25,362\n-\n319,406\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa073.71\n33,035\n62,078\n0\nDong-A ST India Pvt., Ltd\n비상장\n2021.12.03\n경영참여\n109\n693,000\n\xa099.00\n109\n-\n-\n-\n693,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa099.00\n109\n329\n73\nNEUROBO PHARMACEUTICALS, INC.\n상장\n2018.04.27\n경영참여\n43,493\n1,553,669\n\xa048.87\n20,466\n1,250,000\n-\n-7,101\n2,803,669\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa057.15\n13,365\n29,373\n-20,134\n앱티스(주)\n비상장\n2023.12.19\n경영참여\n31,383\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0-\n1,526,980\n31,383\n-\n1,526,980\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa051.47\n31,383\n9,688\n-8,661\n(주)레드엔비아\n비상장\n2019.03.29\n일반투자\n4,000\n333,334\n\xa040.60\n4,000\n26,000\n1,508\n-\n359,334\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa042.22\n5,508\n9,372\n-15,098\n인하브바이오텍7성장사모투자 합자회사\n비상장\n2020.12.17\n일반투자\n3,901\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa046.95\n3,901\n-\n-\n-3,901\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa046.95\n\xa0 \xa0 \xa0 \xa0 \xa0-\n7,819\n-128\n메리츠-엔에스 글로벌바이오투자조합\n비상장\n2018.03.27\n단순투자\n2,905\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 10.34\n758\n-\n-\n-188\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa010.34\n570\n15,303\n-296\n글로벌바이오성장제3호투자조합\n비상장\n2021.06.22\n단순투자\n3,880\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 16.53\n3,424\n-\n-\n-76\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 7.78\n3,348\n42,996\n-1,222\n신한-타임폴리오바이오육성투자조합\n비상장\n2023.06.29\n단순투자\n1,200\n-\n-\n-\n-\n1,200\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 9.70\n1,200\n12,420\n-150\n노벨파마\n비상장\n2020.07.29\n단순투자\n1,003\n92\n\xa00.50\n241\n-\n-\n232\n92\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.50\n473\n8,030\n-13,439\n노벨티노빌리티\n비상장\n2021.02.09\n단순투자\n1,000\n24,295\n\xa01.89\n1,148\n-\n-\n37\n24,295\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1.34\n1,185\n32,125\n-6,896\nGenEdit INC\n비상장\n2023.02.14\n단순투자\n1,275\n-\n-\n\xa0-\n280,567\n1,275\n-\n280,567\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1.19\n1,275\n31,428\n-18,298\n메쥬\n비상장\n2021.11.30\n단순투자\n3,000\n16,608\n\xa04.57\n2,500\n1,938\n500\n730\n18,546\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 4.50\n3,730\n8,612\n-2,803\nAntiva\n비상장\n2020.10.29\n단순투자\n613\n2,441,936\n\xa02.34\n706\n213,242\n165\n396\n2,655,178\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1.69\n1,267\n8,502\n-2,534\n이지메디컴\n비상장\n2001.09.06\n단순투자\n200\n80,000\n\xa00.35\n242\n-\n\xa0-\n20\n80,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.35\n262\n270,648\n8,263\n호유코리아\n비상장\n2005.01.27\n단순투자\n540\n5,400\n\xa020.00\n494\n-\n-\n17\n5,400\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa020.00\n511\n3,136\n47\n오스테오시스\n비상장\n2005.09.01\n단순투자\n31\n139,372\n\xa05.38\n1,636\n-139,372\n-1,636\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n-\n\xa0 \xa0 \xa0 \xa0 -\n34,984\n2,282\nCSTV\n비상장\n2011.01.28\n단순투자\n3,000\n600,000\n\xa00.97\n5,627\n-\n-\n1,714\n600,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.97\n7,341\n472,900\n36,367\nJTBC\n비상장\n2011.02.23\n단순투자\n4,936\n987,147\n\xa00.86\n493\n-\n-\n-49\n987,147\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.86\n444\n390,413\n-66,744\n사이언스메딕\n비상장\n2015.04.30\n단순투자\n223\n4,445\n\xa010.00\n307\n-\n-\n33\n4,445\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa010.00\n340\n9,259\n567\n에스엘바이젠\n비상장\n2019.11.29\n단순투자\n6,385\n473,000\n\xa02.94\n2,637\n-\n-\n247\n473,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2.45\n2,884\n37,715\n-12,482\nPT Combiphar\n비상장\n2017.06.30\n단순투자\n10,841\n5,663\n\xa06.32\n5,976\n-\n-\n-11\n5,663\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 6.32\n5,965\n9,469\n20\nBeactica AB\n비상장\n2018.03.16\n단순투자\n448\n11,504\n\xa03.40\n689\n-\n-\n-322\n11,504\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 3.22\n367\n4,423\n-1,360\nMthera Pharma\n비상장\n2023.07.24\n단순투자\n1,000\n-\n-\n-\n5,000\n1,000\n-\n5,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2.75\n1,000\n-\n-\n합 계\n-\n-\n63,588\xa0\n257,007\n60,452\n-8,222\n-\n-\n115,818\n-\n-\n']"
